Project/Area Number |
20591583
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | University of Occupational and Environmental Health, Japan |
Principal Investigator |
SHIBAO Kazunori University of Occupational and Environmental Health, Japan, 医学部, 助教 (10330987)
|
Co-Investigator(Kenkyū-buntansha) |
HIRATA Keiji 国際医療福祉大学, 保健医療学部, 准教授 (70269059)
YAMAGUCHI Koji 産業医科大学, 医学部, 教授 (50191226)
永田 直幹 産業医科大学, 医学部, 非常勤医師 (80200377)
|
Project Period (FY) |
2008 – 2010
|
Project Status |
Completed (Fiscal Year 2010)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | カルシウムシグナリング / IP3レセプター / 胃癌 / 細胞増殖 / アポトーシス / イノシトール3リン酸受容体 |
Research Abstract |
The inositol 1,4,5-trisphosphate receptor (InsP3R) mediates Ca2+ signaling in epithelia and regulates cellular functions such as secretion, apoptosis and cell proliferation. Loss of one or more InsP3R isoform has been implicated in disease processes such as cholestasis. Here we examined whether gain of expression of InsP3R isoforms also may be associated with development of disease. Expression of all three InsP3R isoforms was evaluated in tissue from gastric carcinomas surgically resected from 40 patients. All subtypes of InsP3Rs were seen in both normal colorectal mucosa and colorectal cancer. Dense apical localization of InsP3 receptors were seen in colorectal mucosa. Meanwhile, diffuse expression of InsP3 receptors were seen in colorectal cancer. No correlation between IP3 receptor expression and clinical parameter were observed in gastric cancer patients. shRNA knockdown of type III InsP3R in CACO-2 colon cancer cells enhanced apoptosis, while over-expression of the receptor decreased apoptosis. Thus, type III InsP3R becomes expressed in human cancer, and its expression level is directly related to aggressiveness of the tumor, which may reflect inhibition of apoptosis by the receptor. These findings suggest a previously unrecognized role for Ca2+ signaling via this InsP3R isoform in human cancer.
|